Open Biology is a prestigious, interdisciplinary journal published by the Royal Society that has been paving the way in the fields of Biochemistry, Genetics and Molecular Biology, Immunology, and Neuroscience since its inception in 2011. Catering to a global audience of researchers, professionals, and students, Open Biology operates under an open access model, facilitating the unrestricted dissemination of high-quality research findings. With a current impact factor that positions its categories in the top quartile (Q1) and impressive Scopus rankings—evidencing its influence and reach—this journal serves as a vital platform for innovators and scientific inquiries aimed at advancing our understanding of life sciences. The journal's commitment to publishing cutting-edge research makes it an essential resource for those at the forefront of scientific exploration.

Biologia Futura, an esteemed journal published by SPRINGER HEIDELBERG, serves as a vital platform for researchers and professionals in the fields of Agricultural and Biological Sciences, as well as Biochemistry, Genetics, and Molecular Biology. Established in Hungary, this journal has been at the forefront of scientific inquiry since its inception in 2019 and continues to contribute significantly to advancing knowledge through rigorous peer-reviewed articles. With current rankings placing it in the second quartile for Agricultural and Biological Sciences and third quartile for Biochemistry, Genetics, and Molecular Biology according to Scopus metrics, it reflects a robust academic quality and reach. Scholars are encouraged to share their original research, reviews, and innovations that intersect these dynamic fields. Although not an open access publication, Biologia Futura ensures wide dissemination of high-impact research from its notable address at Tiergartenstraße 17, D-69121 Heidelberg, Germany, aiming to foster collaboration and discovery within the global scientific community.

Molecular Biology Research Communications is a distinguished academic journal published by Shiraz University, focusing on the critical and rapidly evolving fields of biochemistry and molecular biology. With an ISSN of 2322-181X and an E-ISSN of 2345-2005, this journal serves as an essential platform for researchers, professionals, and students to disseminate significant findings that contribute to the advancement of knowledge in these disciplines. The journal, operating from Shiraz, Iran, is notable for its contributions from both local and international scholars, offering invaluable insights and fostering scientific collaboration. Although currently indexed in the Q4 quartile across its categories, the journal aims to enhance its impact and visibility in the field as it converges years of research from 2017 to 2024. While the open access option is not available, the journal's commitment to high-quality peer-reviewed research provides a respected avenue for publication.

FOLIA BIOLOGICA-KRAKOW, published by the renowned Polish Academy of Sciences, Institute of Systematics and Evolution of Animals, serves as a pivotal platform for advancing research in the fields of Biochemistry, Genetics, and Molecular Biology. Since its inception in 1953, this journal has consistently contributed to the academic dialogue, focusing on a diverse range of topics, including evolutionary biology, molecular genetics, and ecological biochemistry. Although currently classified in Q4 quartiles according to the 2023 categorizations in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Medicine (miscellaneous), its dedicated efforts to disseminate critical findings and foster scholarly exchange ensure its relevance and growth in the scientific community. FOLIA BIOLOGICA-KRAKOW is not Open Access, but researchers can access its publications through institutional subscriptions or library services, making it a valuable resource for scientists seeking to enrich their understanding of biological processes. With its commitment to excellence and innovation in biological research, this journal remains an essential reference for researchers, professionals, and students alike, contributing significantly to the evolution of contemporary biological sciences.

Quantitative Biology is a prestigious journal published by WILEY, focusing on the interdisciplinary study of quantitative approaches in the biological sciences. With an ISSN of 2095-4689 and an E-ISSN of 2095-4697, this journal has established itself as a critical platform for researchers exploring complex biological systems through mathematical and computational methodologies. Operating out of China, Quantitative Biology significantly contributes to its field, holding a Q2 ranking in various categories, including Applied Mathematics and Biochemistry, Genetics and Molecular Biology, according to the latest Scopus rankings. These rankings reflect the journal's commitment to publishing high-quality research that employs advanced modeling and simulation techniques. The journal's impact is evident with its position in the 84th percentile for Applied Mathematics, indicating its relevance and growth in a competitive academic landscape. Although it does not currently operate under an Open Access model, the journal is pivotal for professionals and students alike, aiming to bridge the gap between mathematical theories and biological applications. Researchers are encouraged to submit their innovative findings and engage with the vibrant community dedicated to advancing the quantitative understanding of biological phenomena.

Frontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.

DNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.

CURRENT BIOLOGY is a premier academic journal published by CELL PRESS, dedicated to a broad spectrum of fields within biological sciences. With an ISSN of 0960-9822 and E-ISSN 1879-0445, the journal has established itself as a vital resource for groundbreaking research and advancements since its inception in 1991. CURRENT BIOLOGY boasts high prominence in its categories, securing a Q1 quartile ranking in Agricultural and Biological Sciences, Biochemistry, Genetics and Molecular Biology, and Neuroscience, indicating its significant impact and relevance in these fields. Notably, it ranks #9 out of 221 journals in Agricultural and Biological Sciences, placing it in the 96th percentile, while also maintaining a strong presence in the Biochemistry category with a rank of #26. Researchers and professionals can rely on CURRENT BIOLOGY for comprehensive reviews, innovative methodologies, and crucial scientific developments that bridge theoretical knowledge with practical applications. The journal continues to play an essential role in enhancing the global dialogue in biological research, making it indispensable for students, academics, and industry experts aiming to stay at the forefront of the rapidly evolving landscape of life sciences.

COMPTES RENDUS BIOLOGIES, published by the esteemed Académie des Sciences, is a prominent journal based in France that contributes significantly to the fields of Agricultural and Biological Sciences, Biochemistry, Genetics and Molecular Biology, as well as Immunology and Microbiology. With a notable Q3 ranking in several categories as of 2023, this journal serves as an essential platform for disseminating groundbreaking research and advancements in these disciplines. Access is currently available under open access options, enhancing the reach and accessibility of its published findings. The journal has been in continuous publication since 1959, with a current focus extending to 2024, ensuring that it remains at the forefront of scientific communication. With its diverse scope and commitment to quality research, COMPTES RENDUS BIOLOGIES plays a crucial role in fostering dialogue and collaboration among researchers, professionals, and students who are dedicated to understanding and addressing complex biological questions.

ACTA HISTOCHEMICA, a prestigious journal published by Elsevier GmbH, is dedicated to advancing the field of histochemistry and its applications within cell biology and medicine. With an ISSN of 0065-1281 and an E-ISSN of 1618-0372, the journal provides a critical platform for the dissemination of high-quality research findings and reviews, integral for both emerging and established scholars. Since its inception in 1954 and continuing through to 2024, ACTA HISTOCHEMICA has maintained a strong commitment to publishing significant advancements in histology and cell biology, as evidenced by its categorization in Q3 for Cell Biology and Histology, as well as Q2 in miscellaneous medicine for the year 2023. The journal ranks favorably in Scopus, holding the 27th rank in Histology and a 200th rank in Cell Biology, highlighting its importance to the academic community. With its headquarters in Munich, Germany, ACTA HISTOCHEMICA continues to attract contributions from global researchers, fostering an international dialogue essential for the growth of knowledge in histochemistry and related disciplines.